<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<channel>
	<title>Diagnostics Product Guide &#187; RSV</title>
	<atom:link href="http://blog.diagnosticsproductguide.com/tag/rsv/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.diagnosticsproductguide.com</link>
	<description>A comprehensive guide to cardiology products for medical professionals </description>
	<lastBuildDate>Wed, 29 Sep 2010 11:14:50 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.3</generator>
		<item>
		<title>Quidel receives CLIA waiver for QuickVue RSV test</title>
		<link>http://blog.diagnosticsproductguide.com/2008/03/03/quidel-receives-clia-waiver-for-quickvue-rsv-test/</link>
		<comments>http://blog.diagnosticsproductguide.com/2008/03/03/quidel-receives-clia-waiver-for-quickvue-rsv-test/#comments</comments>
		<pubDate>Mon, 03 Mar 2008 19:33:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Point of Care Testing]]></category>
		<category><![CDATA[bronchiolitis]]></category>
		<category><![CDATA[CLIA]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[pneumonia]]></category>
		<category><![CDATA[QuickVue]]></category>
		<category><![CDATA[Quidel]]></category>
		<category><![CDATA[respiratory syncytial virus]]></category>
		<category><![CDATA[RSV]]></category>
		<guid isPermaLink="false">http://www.diagnosticsproductguide.com/blog/2008/03/03/quidel-receives-clia-waiver-for-quickvue-rsv-test/</guid>
		<description><![CDATA[Quidel Corporation has announced that the FDA has granted a CLIA (clinical laboratory improvement amendments) waiver for the QuickVue test. This test enables the qualitative detection of the respiratory syncytial virus (RSV). The American Academy of Pediatrics has recognized RSV as the primary cause of pneumonia and bronchiolitis in children of 2 years of age [...]]]></description>
			<content:encoded><![CDATA[<p><img border="0" vspace="5" align="right" width="244" src="http://blog.diagnosticsproductguide.com/files/2008/03/quickvue-rsv.jpg" hspace="5" alt="QuickVue RSV" height="157" /><a href="http://www.quidel.com/">Quidel Corporation</a> has announced that the FDA has granted a CLIA (clinical laboratory improvement amendments) waiver for the QuickVue test. This test enables the qualitative detection of the respiratory syncytial virus (RSV). The American Academy of Pediatrics has recognized RSV as the primary cause of pneumonia and bronchiolitis in children of 2 years of age and below. The waiver allows the QuickVue RSV test to be made more widely available for use, especially in clinics and offices of physicians, where waived tests are used most frequently.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.diagnosticsproductguide.com/2008/03/03/quidel-receives-clia-waiver-for-quickvue-rsv-test/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

